Rankings
▼
Calendar
AVBP Q1 2022 Earnings — ArriVent BioPharma, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
AVBP
ArriVent BioPharma, Inc. Common Stock
$1B
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-5.76
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$99,000
Balance Sheet
Total Assets
$0
Total Liabilities
-$41M
Stockholders' Equity
$41M
Cash & Equivalents
$0
← FY 2022
All Quarters
Q2 2022 →
